# Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

> **NCT02160665** · PHASE3 · COMPLETED · sponsor: **G & W Laboratories Inc.** · enrollment: 866 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** Tazarotene Cream, 0.05%
- **DRUG:** Vehicle
- **DRUG:** Reference: Tazorac Cream, 0.05%

## Key facts

- **NCT ID:** NCT02160665
- **Lead sponsor:** G & W Laboratories Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 866 (ACTUAL)
- **Last updated:** 2016-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02160665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02160665, "Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02160665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*